Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...

Pyxis Oncology (PYXS) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to PYX-201 for the treatment of ...

Pyxis Oncology (PYXS) stock rises as the FDA issues fast track designation for its lead asset PYX-201 in head and neck cancer ...

头颈部鳞状细胞癌（HNSCC）是全球第六大常见癌症，初始治疗后复发和转移率高，是一个重要的健康问题。这些患者的中位总生存期不到一年，凸显了新治疗方案的迫切需求。虽然Pyxis Oncology的股票面临挑战，目前交易价格接近52周低点1.19美元，但 InvestingPro 分析表明该公司目前被低估。在 最被低估股票 页面了解更多被低估机会。

Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have received an average recommendation of “Moderate Buy” from ...

ADGM has successfully completed its jurisdictional expansion to integrate Al Reem Island, solidifying its position as one of ...

Vehicle Insite provides detailed vehicle analytics, including class, count, speed, and state of origin, offering planners a holistic view of roadway usage. Its EV analytics identify EV volumes and ...

RISE is thrilled to announce that 141 sponsors will exhibit at RISE National 2025—the annual event that is the #1 trusted source for all things Medicare Advantage—when it heads to the Henry B.

在生物科技公司面临挑战的时期，Pyxis Oncology股价触及新的52周低点1.23美元，较52周高点6.85美元下跌82%。根据 InvestingPro 分析，该公司保持着7.33的强劲流动比率，但目前正在快速消耗现金。在市场环境艰难的情况下，随着投资者对该板块相关风险的担忧加剧，公司股价大幅下跌。过去一年，Pyxis ...

▲2025年2月18日，《哪吒之魔童闹海》登顶全球动画电影票房榜首。图据视觉中国上映21天，《哪吒之魔童闹海》（下称《哪吒2》）登顶全球动画电影票房榜榜首。这21天里，《哪吒2》打破的国内票房纪录数不胜数，更是史无前例地打破多个国际票房纪录。《哪吒2 ...